Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The proposed clinical trial endpoints are the resolution of steatohepatitis without worsening or liver fibrosis and/or improvement in liver fibrosis one stage or greater without worsening of steatohepatitis
Yet choosing a GLP-1 medication isnt a decision to make on a whim
Code availability All the statistical analyses in this study including propensity-score matching and KaplanMeier Survival analyses were conducted within the TriNetX platform by using its built-in functions
The published Phase 2 data is the practical demonstration that the balance was achieved
W.KennaJ
:max_bytes(150000):strip_icc()/GettyImages-2212016418-9aca914e0a0549ceb1d23a13e16da387.jpg)
In a 72-week study, participants experienced an average weight loss of 15-21% when taking different doses of Tirzepatide (5 mg, 10 mg, or 15 mg)
US$ 22.96
US$ 29.42
US$ 22.34
US$ 25.24
US$ 29.16
